Document:

Amendmnt 1 to Services Agreement

 Exhibit 10.18 
 SPECIFIC TERMS IN THIS EXHIBIT HAVE BEEN REDACTED BECAUSE CONFIDENTIAL TREATMENT FOR THOSE TERMS HAS BEEN REQUESTED. THE REDACTED MATERIAL HAS BEEN SEPARATELY FILED WITH THE SECURITIES AND EXCHANGE COMMISSION, AND THE REDACTED TERMS HAVE
BEEN MARKED IN THIS EXHIBIT AT THE APPROPRIATE PLACE WITH TWO ASTERISKS [**]. 
 Amendment No. 1 to Services Agreement 
 Reference is made to that certain Services Agreement, dated as of July 24, 2000, between Tenet HealthSystem Medical, Inc., for itself and its
affiliates, and Innovative Managed Care Systems, Inc. (the “Agreement”). The parries to the Agreement wish to amend certain terms and provisions as described in this Amendment No. 1 to the Agreement (“Amendment No. 1”).
Unless otherwise specified in this Amendment No. 1, all other terms and provisions shall remain in full force and effect and unchanged. Capitalized terms used herein without definition shall have the meanings ascribed thereto in the Agreement.

 The parties hereto hereby agree to amend the Agreement, effective as of the date hereof, solely as follows: 
  

	 	1.	Sections 4.1 and 4.4 are hereby revised, in each case, solely to change the stated notice period 

 from one hundred eighty (180) days to three hundred sixty 360 days. 
  

	 	2.	A new Section 7.7 is added to the Agreement as follows: 

  

	 	7.7	The fees payable under the terms of this Agreement shall be subject to annual increases, provided that IMaCs provides Tenet with written notice of any such increase at least 90 days
prior to the expiration of each one-year period. Annual increases shall in no event exceed the lesser of: (i) a percentage increase equal to the percentage increase in the Consumer Price Index for Urban Consumers, All Cities Average, For all
Items (1998=100), as published by the Bureau of Labor Statistics of the United States Department of Labor during the most recent twelve-month period for which such figures are available; or (ii) four percent (4%). 

  

	 	3.	Schedule C to the Agreement is hereby replaced in its entirety with the Schedule C attached hereto as Exhibit A. 

 Except as otherwise provided herein, all provisions of the Agreement remain unchanged and in full force and effect. 
 IN WITNESS WHEREOF, the parries have caused this Amendment No. 1 to be executed by their authorized representatives as of
July 18, 2003. 
  

									
	Tenet HealthSystem Medical, Inc.	 		 	Innovative Managed Care Systems, Inc.
					
	By:	 	/s/ Donna L. Nichols	 		 	By:	 	/s/ Gary Cohen
	Name:	 	Donna Nichols	 		 	Name:	 	Gary Cohen
	Title:	 	VP, ISD	 		 	Title:	 	COO
	Date:	 	7/18/03	 		 	Date:	 	7/18/03

 SCHEDULE C 
 FEE SCHEDULE 
 Base Fees: 
 Pricing 

 

			
	 Monthly Service Fees:1,2 Per Hospital
(months 1-6 of implementation)
	  	$[**] per month
	 Per Hospital (months 7 and beyond)
	  	$[**] per month
		
	 Contract Loading Fees (new contracts and updates):3
	  	
	 IMaCS performs all functions
	  	$[**] per rate schedule
	 Tenet personnel do analysis and build terms document
	  	$[**] per rate schedule
	 Contract deferred/cancelled by Tenet prior to start of loading
	  	$[**] per rate schedule
	 Contract deferred/cancelled by Tenet after the start of loading
	  	$[**] per rate schedule
		
	 Programming and Development5
	  	$[**] per hour
	 Contract Negotiation Support
	  	$[**] per hour

 Monthly Billing (first of month): 
 Associated hospital processing fees for current month 
 Contract
loading fees for prior month3 
 Contract loading fees associated with deferred/cancelled contracts in prior month3 
 Associated hourly fees for Programming and Contract Negotiation Support 
  

	 1
	 The Monthly Service Fee covers all normal work done in connection with this agreement as currently performed by IMaCS.
For billing purposes, a Central Business Office (CBO) does not count as a Hospital. In the event Tenet desires additional services under this agreement, Tenet will submit a Development/Service Request. The parties shall renegotiate in good faith the
Monthly Service Fee should the additional service increase the normal workload for IMaCS on an ongoing basis. IMaCS will make best efforts to satisfy the needs of the Tenet hospital clients. Facility requests outside the scope of normal processing
should be submitted through a Development/Service Request. 

  

	 2
	 When processing only Medicare claims for a facility, IMaCS will bill the lower monthly rate set forth above (and
identified as for hospitals where implementation occurred 7 months and beyond) until such time as the facility actually begins Managed Care implementation. At that time, the facility will be billed at the higher rate (relating to the first 6 months
of implementation) reverting to the lower rate after six months. 

  

	 3
	 Hospitals that start implementation after the 16th of the month will not be billed a monthly fee during the initial month. Hospitals that begin implementation prior to the 16th of the month will be charged a full monthly fee. Implementation start date is defined as the date the initial set of executed contract documents are received. 

  

	 4
	 Contract loading fees will be invoiced whenever: (1) the loading process reaches the Ready for Production (as
defined below) phase or 45 calendar days after the loading process reaches the Client Audit (as defined below) phase, whichever event occurs sooner; or (2) Tenet instructs IMaCS to abandon the loading process for a rate schedule. During the
transition period when moving from hourly to flat rates: (1) Tenet will not be credited with previously paid hourly charges for rate schedules which have not reached the Client Audit stage; (2) IMaCS will not receive additional hourly
payments for rate schedules that have progressed beyond the Client Audit stage as of the billing conversion date. For purposes of this Amendment No. 1, (i) Ready for Production” shall mean that the terms for the specific rate schedule
have been loaded into the Software and Tenet has reviewed and approved the adjudication results; and (ii) “Client Audit” shall mean that the terms for the specific rate schedule have been loaded into the Software, IMaCs has tested
adjudication results, and it is ready for Tenet review. 

  

	 5
	 Time spent by IMaCS development personnel interfacing to the Data Exchange Server, Digital Claims, or any Tenet
corporate system is not included in the base service and is billed at the hourly rate for Programming and Development. 

 [**] CERTAIN
INFORMATION ON THIS PAGE HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS.Amended and Restated Employment Agreement dated November 8, 2007

 Exhibit 10.27 
 AMENDED AND RESTATED EMPLOYMENT AGREEMENT 
 THIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT
(“Agreement”) is made and entered into on November 8, 2007, by and between Zhone Technologies, Inc., a Delaware corporation (the “Company”) and Mory Ejabat (“Executive”). 
 WHEREAS, the Company and Executive are parties to that certain Employment Agreement dated as of October 20, 1999 (the “Prior Agreement”);

 WHEREAS, the Company desires to continue to Executive as Chief Executive Officer (“Title”) of the Company and Executive desires
to continue to be so engaged by the Company in such positions, on the terms and conditions set forth and described herein; 
 WHEREAS, the
parties desire to amend and restate the Prior Agreement on the terms and conditions set forth herein. 
 NOW, THEREFORE, in consideration of
the premises and the mutual covenants and agreements herein contained, the parties agree as follows: 
 1. Employment. The Company
hereby agrees to employ Executive, and Executive hereby agrees to serve, subject to the provisions of this Agreement, as an employee of the Company in the position of Chief Executive Officer. Executive shall perform all services and acts necessary
to fulfill the duties and responsibilities of his position and shall render such services on the terms set forth herein and shall report to the Company’s Board of Directors (the “Board of Directors”). In addition, Executive shall have
such other executive and managerial powers and duties with respect to the Company as may reasonably be assigned to him by the Board of Directors, to the extent consistent with his positions and status as set forth above. Except as otherwise approved
by a majority of the Board of Directors, Executive agrees to devote all his business time, attention and energies to the performance of the duties assigned hereunder, and to perform such duties diligently, faithfully and to the best of his
abilities. Except as otherwise approved by a majority of the Board of Directors, Executive agrees to refrain from any business activity that does’, will or could reasonably be deemed to materially conflict with the best interests of the
Company. 
 2. Term. The term of Executive’s employment pursuant to this Agreement is for the four-year period (the
“Term”) commencing on the date hereof and terminating on October 20, 2008, or upon the date of earlier termination of employment pursuant to Section 8 of this Agreement; provided, however, that commencing on the October 20,
2008 and each anniversary thereafter the Term shall automatically be extended for one additional year unless, not later than ninety (90) days prior to any such anniversary, either party hereto shall have notified the other party in writing
hereto that such extension shall not take effect. 
 3. Place of Performance. The Executive shall perform his duties and conduct his
business at the principal executive offices of the Company, except for required travel on the Company’s business. 
 4.
Compensation. 
 (a) Salary. Executive’s salary shall be determined on at least an annual basis by the Compensation
Committee of the Board of Directors (the “Annual Salary”) and payable in accordance with the Company’s regular payroll practices. All applicable withholding taxes shall be deducted from such payments. 
 (b) Bonus. During each year of the Term, the Board of Directors shall review the Executive’s performance, and may, in its sole discretion,
cause to be paid to Executive a bonus in addition to the Annual Salary. 
 5. Business Expenses. During the Term, the Company will
reimburse Executive for all ordinary and necessary business expenses incurred by him in connection with his employment upon timely submission by the Executive of receipts and other documentation in conformance with the Company’s normal
procedures. 
 6. Vacation, Holidays and Sick Leave. During the Term, Executive shall be entitled to paid vacation, paid holidays and
sick leave in accordance with the Company’s standard policies for its officers. 

 7. Benefits. During the Term, Executive shall be eligible to participate fully in all health
benefits, insurance programs, pension and retirement plans and other employee benefit and compensation arrangements (collectively, the “Employee Benefits”) available to officers of the Company generally. 
 8. Termination of Employment. 
 (a)
Notwithstanding any provision of this Agreement to the contrary, employment of Executive hereunder shall terminate on the first to occur of the following dates: 
 (i) the date of Executive’s death or adjudicated incompetency; 
 (ii) the date on which Executive
shall have experienced a Disability (as defined below), and the Company terminates Executive’s employment on account of Disability; 
 (iii) the date on which Executive’s employment is terminated by the Company for Cause (as defined below); 
 (iv) expiration
of the Term; 
 (v) the date on which Executive’s employment is terminated by the Company for any reason other than the reasons set
forth in (1) through (iv) above; 
 (vi) the date on which Executive resigns his employment for Good Reason (as defined below); or

 (vii) the date on which Executive resigns his employment for a reason other than Good Reason. 
 (b) For purposes of this Agreement, “Disability” shall mean an illness, injury or other incapacitating condition as a result of which Executive
is substantially unable to perform the services required to be performed under this Agreement for (i) one hundred eighty (180) consecutive days during the Term; or (ii) a period or periods aggregating more than two hundred forty
(240) days in any period of twelve (12) consecutive months during the Term. In the event the Company seeks to terminate Executive’s employment due to Disability, the Company shall give notice to Executive of the termination of
Executive’s employment for Disability. Executive agrees to submit to such medical examinations as may be necessary to determine whether a Disability exists, pursuant to such reasonable requests made by the Company from time to time. Any
determination as to the existence of a Disability shall be made by a physician approved by the Board of Directors and by Executive (or, if Executive is unable to give such approval, by Executive’s representative), which approval shall not be
unreasonably withheld by the Board of Directors or Executive. 
 (c) For purposes of this Agreement, “Cause” shall mean the
occurrence of any of the following events: 
 (i) The reasonable determination of the Board of Directors that Executive has willfully or
continually failed to substantially perform his duties with the Company. 
 Notwithstanding the foregoing, Cause shall only exist under this
Section 8(c)(i) if: 
 (A) the Board of Directors has given Executive written notice that it has reasonably determined Executive has
willfully or continually failed to substantially perform his duties with the Company, which notice shall identify with specificity the duties the Board of Directors has reasonably determined Executive to have willfully or continually failed to
substantially perform; and 
 (B) at the end of the period ending sixty (60) days from the date on which the notice in
Section 8(c)(i)(A) is given by the Board of Directors to Executive, the Board of Directors reasonably determines that Executive has failed to cure the willful or continual failure to substantially perform his duties identified with specificity
in the written notice described in Section 8(c)(i)(A); 
 (ii) Executive’s conviction of, guilty plea to, or entry of a nolo
contendere plea to a felony. 

 Notwithstanding the foregoing, the parties acknowledge and agree that: 
 (A) at the end of two hundred seventy (270) days from the date of the finding of an indictment or filing of an information against Executive for a
felony, any vesting of the “Unvested Interest” described in the Class B Member Interest Purchase Agreement shall be suspended pending the outcome of the criminal proceedings, including the appeals. If, subsequent to the finding of
indictment or filing of information, (1) Executive is found not guilty of the felony charge, (2) the felony charge against Executive is dismissed for any reason, or (3) a conviction of Executive for the felony is reversed or vacated
on appeal, any unvested portions of the “Unvested Interest” described in the Class B Member Interest Purchase Agreement shall immediately vest. 
 (iii) The reasonable determination of the Board of Directors that Executive has engaged in willful or reckless misconduct that has caused or is reasonably likely to cause demonstrable and material financial injury to
the Company. 
 Notwithstanding the foregoing, Cause shall only exist under this Section 8(c)(iii) if. 
 (A) the Board of Directors has given Executive written notice that the Board of Directors has reasonably determined that Executive has committed willful
or reckless misconduct which has caused or is reasonably likely to cause demonstrable and material financial injury to the Company, which notice shall identify with specificity the willful or reckless misconduct the Board of Directors has reasonably
determined Executive to have committed; and 
 (B) at the end of the period ending sixty (60) days after the date on which the notice
described in Section 8(c)(iii)(A) is given by the Board of Directors to Executive, the Board of Directors reasonably determines that Executive has failed to cure the willful or reckless misconduct identified with specificity in the notice
described in Section 8(c)(iii)(A); or 
 (iv) Executive’s willful and material breach of Sections 11, 12, or 13 of this Agreement;

 Notwithstanding the foregoing, Cause shall only exist under this Section 8(c)(iv) only if 
 (A) the Board of Directors have given written notice to Executive of their intent to terminate Executive for Executive’s willful and material
breach of Section 11, 12, or 13 of this Agreement; and 
 (v) Executive has failed to cure the adverse effects of Executive’s
willful and material breach of Section 11, 12, or 13 of this Agreement within the time period afforded Executive in the Board of Directors’ notice described in Section 8(c)(iv)(A), which time period shall be no less than sixty
(60) days after the Company provides Executive with notice of the Board of Directors’ intent to terminate Executive for Cause. 
 For purposes of Sections 8(c)(i), (iii) and (iv), an act on Executive’s part shall not be deemed “willful,” “reckless,” or “continual” if done by Executive in good faith and with reasonable belief
that the act was in the best interest of the Company. 
 (d) For purposes of this Agreement, “Good Reason” shall mean the
occurrence of any of the following events without the Executive’s consent: 
 (i) a material diminution in Executive’s base
compensation; 
 (ii) a material diminution in Executive’s authority, duties or responsibilities, including a requirement that
Executive report to a corporate officer or employee instead of reporting directly to the Board of Directors; 
 (iii) a material change
in the geographic location at which Executive must perform his duties; or 
 (iv) any other action or inaction that constitutes a
material breach by the Company of its obligations to Executive under this Agreement. 
 Notwithstanding the foregoing, Good Reason shall only
exist if Executive shall have provided the Company with ninety (90) days written notice of the initial occurrence of any of the foregoing events or conditions, and the 

 
Company fails to eliminate the conditions constituting Good Reason within thirty (30) days after receipt of written notice of such event or condition
from Executive. Executive’s termination by reason of resignation from employment with the Company for Good Reason shall be treated as involuntary. Executive’s resignation from employment with the Company for Good Reason must occur within
two (2) years following the initial existence of the act or failure to act constituting Good Reason. 
 9. Compensation in Event of
Termination. Upon termination of the Term for any reason, the Company shall have no further obligation to Executive except to pay the amounts set forth in this Section 9. 
 (a) In the event Executive’s employment is terminated pursuant to Sections 8(a)(i), (ii), (iii) (iv), or (vii) during or at the expiration
of the Term, Executive or his estate, conservator or designated beneficiary, as the case may be, shall be entitled to payment of any earned but unpaid Annual Salary through the date of termination, as well as any accrued vested benefits to which
Executive is entitled. Following any such termination, neither Executive nor his estate, conservator or designated beneficiary shall be entitled to receive any other payment provided for hereunder with respect to any period after such termination,
except as Executive may otherwise be entitled pursuant to any employee benefit plan. 
 (b) In the event Executive’s employment is
terminated pursuant to Section 8(a)(v) or (vi) during the Employment Term, Executive shall be entitled to receive, as his sole and exclusive remedy, (x) payment of any earned but unpaid Annual Salary through the date of termination,
as well as any accrued vested benefits to which Executive is entitled and (y) a lump sum payment within ten (10) days following the date of Executive’s termination of employment equal to Executive’s Annual Salary as in effect
immediately prior to the date of termination. 
 (c) This Agreement is not intended to
provide for any deferral of compensation subject to Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”), and, accordingly, the severance payment payable under Section 9(b)(y) shall be paid no later than the
later of: (i) the fifteenth (15th) day of the third month following Executive’s first taxable year in which such severance benefit is
no longer subject to a substantial risk of forfeiture, and (ii) the fifteenth (15th) day of the third month following the first taxable
year of the Companies in which such severance benefit is no longer subject to a substantial risk of forfeiture, as determined in accordance with Code Section 409A and any Treasury Regulations and other guidance issued thereunder. To the extent
applicable, this Agreement shall be interpreted in accordance with Code Section 409A and Department of Treasury regulations and other interpretive guidance issued thereunder. 
 (d) Notwithstanding anything to the contrary in this Agreement, if at the time of Executive’s termination of employment with the Company Executive
is a “specified employee” as defined in Code Section 409A, as determined by the Company in accordance with Code Section 409A, to the extent that the payments or benefits under this Agreement are subject to Code Section 409A
and the delayed payment or distribution of all or any portion of such amounts to which Executive is entitled under this Agreement is required in order to avoid a prohibited distribution under Code Section 409A(a)(2)(B)(i), then such portion
shall be paid or distributed to Executive during the thirty (30) day period commencing on the earlier of (x) the date that is six (6) months following Executive’s termination of employment with the Company, (y) the date of
Executive’s death, or (z) the earliest date as is permitted under Code Section 409A. 
 (e) As provided in Internal Revenue
Notice 2006-79 and Internal Revenue Notice 2007-86, notwithstanding any other provision of this Agreement, with respect to an election or amendment to change a time and form of payment under this Agreement made on or after January 1, 2007 and
on or before December 31, 2007, the election or amendment may apply only to amounts that would not otherwise be payable in 2007 and may not cause an amount to be paid in 2007 that would not otherwise be payable in 2007. 
 10. Representations. 
 (a) The
Company represents and warrants that this Agreement has been authorized by all necessary corporate action of the Company and is a valid and binding agreement of the Company enforceable against them in accordance with its terms. 
 (b) The Executive represents and warrants that he is not a party to any agreement or instrument which would prevent him from entering into or performing
his duties in any way under this Agreement. 
 11. Disclosure and Assignment of Inventions. 
 (a) Executive has provided on Exhibit A, attached hereto, a list describing all inventions, original 

 
works of authorship, developments, improvements, and trade secrets which were made by Executive prior to employment with the Company, which belong to
Executive alone or jointly with others, which relate to the Company’s proposed business, products or research and development, and which are not assigned to the Company; if “none” is stated on Exhibit A, Executive therefore
represents that there are no such inventions, works of authorship, developments, improvements or trade secrets. 
 (b) Executive agrees to
promptly make full written disclosure to the Company, will hold in trust for the sole right and benefit of Company, and hereby assigns to Company all right, title, and interest in and to any and all inventions (and patent rights with respect
thereto), original works of authorship (including all copyrights with respect thereto), developments, improvements or trade secrets which Executive may solely or jointly conceive or develop or reduce to practice, or cause to be conceived or
developed or reduced to practice during the Term. 
 (c) Executive understands that the provisions of this Agreement requiring assignment to
the Company do not apply to any invention made by an employee of the Company which qualifies fully under the provisions of Section 2870 of the California Labor Code which provides: 
 “(a) Any provision in an employment agreement which provides that an employee shall assign, or offer to assign, any of his or her rights in an
invention to his or her employer shall not apply to an invention that the employee developed entirely on his or her own time without using the employer’s equipment, supplies, facilities, or trade secret information except for those inventions
that either: (1) Relate at the time of conception or reduction to practice of the invention to the employer’s business, or actual or demonstrably anticipated research or development of the employer; or (2) Result from any work
performed by the employee for the employer. (b) To the extent a provision in an employment agreement purports to require an employee to assign an invention otherwise excluded from being required to be assigned under Subdivision (a), the
provision is against the public policy of this state and is unenforceable.” 
 Executive agrees to advise the Company promptly in writing of any
inventions that he believes meet the criteria of Section 2870 of the California Labor Code, and will also provide at that time to the Company in writing all evidence necessary to substantiate that belief. The Company will keep in confidence and
will not disclose to third parties without Executive’s consent any confidential information disclosed in writing to the Company relating to inventions that qualify full under the provisions of Section 2870 of the California Labor Code.

 12. Confidentiality. Executive acknowledges that in his employment hereunder he will occupy a position of trust and confidence. The
Executive covenants and agrees that he will not at any time during and after the end of the Term, directly or indirectly, use for his own account, or disclose to any person, firm or corporation, other than authorized officers, directors and
employees of the Company or its subsidiaries, Confidential Information (as hereinafter defined) of the Company and its subsidiaries or affiliates. As used herein, “Confidential Information” means information about the Company and its
subsidiaries or affiliates of any kind, nature or description, including but not limited to, any proprietary knowledge, trade secrets, data, formulae, information and client and customer lists and all papers, resumes, and records (including computer
records) which is disclosed to or otherwise known to the Executive as a direct or indirect consequence of his association with the Company, which information is not generally known to the public or in the businesses in which the Company is engaged
or which information relates to specific investment opportunities within the scope of the Company’s business which were considered by the Executive or the Company during the term of this Agreement. Executive acknowledges that such Confidential
Information is specialized, unique in nature and of great value to the Company and its subsidiaries, and that such information gives the Company and its subsidiaries a competitive advantage. Executive agrees to deliver or return to the Company, at
the Company’s request at any time or upon termination or expiration of his employment or as soon thereafter as possible, all documents, computer tapes and disks, records, lists, data, drawings, prints, notes and written information (and all
copies thereof) furnished by the Company and its subsidiaries or affiliates or prepared by Executive during the term of his employment by the Company and its subsidiaries or affiliates. 
 13. Nonsolicitation. 
 (a)
Customers and Suppliers. During the Term and, for a period of nine (9) months beyond the expiration of the Term, Executive shall not, directly or indirectly, influence or attempt to influence customers or suppliers of the Company or any
of its subsidiaries or affiliates to divert their business to any competitor of the Company. 
 (b) Employees. Executive recognizes
that he will possess confidential information about other employees of the Company and its subsidiaries and affiliates relating to their education, experience, skills, abilities, compensation and benefits, and inter-personal relationships with
customers of the Company and its subsidiaries and affiliates. 

 
Executive recognizes that the information he will possess about these other employees is not generally known, is of substantial value to the Company and its
subsidiaries in developing its business and in securing and retaining customers, and will be acquired by him because of his business position with the Company and its subsidiaries and affiliates. Executive agrees that, during the Term and for a
period of nine (9) months beyond the expiration of the Term, he will not, directly or indirectly, induce, solicit or recruit any employee of the Company or its subsidiaries or affiliates for the purpose of being employed by him or by any
competitor of the Company on whose behalf he is acting as an agent, representative or employee, and that he will not convey any such confidential information or trade secrets about other employees of the Company and its subsidiaries or affiliates to
any other person. 
 (c) Reasonableness of Relief; Blue Penciling. Executive acknowledges and agrees that the covenants and agreements
contained herein are reasonable and valid in geographic and temporal scope and in all other respects and are reasonably necessary to protect the Company. If any court determines that any of the covenants and Agreements contained herein, or any part
thereof, is unenforceable because of the duration or geographic scope of such provision, such court shall have the power to reduce the duration or scope of such provision, as the case may be, and, in its reduced form, such provision shall then be
enforceable to the maximum extent permitted by applicable law. 
 14. Rights and Remedies upon Breach. In the event Executive
breaches, or threatens to commit a breach of, any of the provisions of this Agreement, the Company and its subsidiaries, affiliates, successors or assigns shall have the following rights and remedies, each of which shall be independent of the others
and severally enforceable, and each of which shall be in addition to, and not in lieu of, any other rights or remedies available to the Company or its subsidiaries, affiliates, successors or assigns at law or in equity under this Agreement or
otherwise: 
 (a) Specific Performance. The right and remedy to have each and every one of the covenants in this Agreement specifically
enforced and the right and remedy to obtain injunctive relief, it being agreed that any breach or threatened breach of any of the nonsolicitation or other restrictive covenants and agreements contained herein would cause irreparable injury to the
Company and its subsidiaries, affiliates, successors or assigns and that money damages would not provide an adequate remedy at law to the Company and its subsidiaries, affiliates, successors or assigns. 
 (b) Accounting. The right and remedy to require Executive to account for and pay over to the Company and its subsidiaries, affiliates, successors
or assigns, as the case may be, all compensation, profits, monies, accruals, increments or other benefits derived or received by Executive that result from any transaction or activity constituting a breach of this Agreement. 
 (c) Enforceability in all Jurisdictions. Executive intends to and hereby confers jurisdiction to enforce each and every one of the covenants and
agreements contained herein upon the courts of any jurisdiction within the geographic scope of such covenants and agreements. If the courts of any one or more of such jurisdictions hold any such covenant or agreement unenforceable by reason of the
breadth or such scope or otherwise, it is the intention of Executive and the Company that such determination shall not bar or in any way affect the Company’s or any of its subsidiaries’, Affiliates’, successors’ or assigns’
right to the relief provided above in the courts of any other jurisdiction within the geographic scope of such covenants and agreements, as to breaches of such covenants and agreements in such other respective jurisdictions, such covenants and
agreements as they relate to each jurisdiction being, for this purpose, severable into diverse and independent covenants and agreements. 
 15. Key Person Insurance. Upon Executive passing any required physical examination, the Company shall use reasonable efforts to procure and keep at its expense an insurance policy or policies on the life of Executive in an amount of
$100,000,000, or such lesser amount as the Board of Directors may determine, payable to such beneficiaries as the Company may from time to time designate. Such policies shall be owned by the Company, and Executive shall cooperate in the obtaining of
all such insurance policies as the Company may desire to apply for and own for its own purposes. This insurance is in addition to any group life coverage which may be provided to Executive by the Company. 
 16. Binding Agreement. This Agreement is a personal contract and the rights and interests of the Executive hereunder may not be sold, transferred,
assigned, pledged, encumbered, or hypothecated by him. This Agreement shall inure to the benefit of and be enforceable by the Executive and his personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees
and legatees. If the Executive should die while any amount would still be payable to him hereunder had the Executive continued to live, all such amounts, unless otherwise provided herein, shall be paid in accordance with the terms of this Agreement
to his devisee, legatee or other designee or, if there is no such designee, to his estate. 
 17. Return of Company Property.
Executive agrees that following the termination of his employment for any 

 
reason, he shall return all property of the Company, its subsidiaries, affiliates and any divisions thereof he may have managed which is then in or
thereafter comes into his possession, including, but not limited to, documents, contracts, agreements, plans, photographs, books, notes, electronically stored data and all copies of the foregoing as well as any materials or equipment supplied by the
Company to Executive. 
 18. Entire Agreement. This Agreement contains all the understandings between the parties hereto pertaining to
the matters referred to herein, and supersedes all undertakings and agreements, whether oral or in writing, previously entered into by them with respect thereto, including, without limitation, the Prior Agreement. Executive represents that, in
executing this Agreement, he does not rely and has not relied upon any representation or statement not set forth herein made by the Company with regard to the subject matter, bases or effect of this Agreement or otherwise. 
 19. Amendment or Modification, Waiver. No provision of this Agreement may be amended or waived unless such amendment or waiver is agreed to in
writing, signed by Executive and by a duly authorized officer of the Company. The failure of either party to this Agreement to enforce any of its terms, provisions or covenants shall not be construed as a waiver of the same or of the right of such
party to enforce the same. Waiver by either party hereto of any breach or default by the other party of any term or provision of this Agreement shall not operate as a waiver of any other breach or default. 
 20. Notices. Any notice to be given hereunder shall be in writing and shall be deemed given when delivered personally, sent by courier or fax or
registered or certified mail, postage prepaid, return receipt requested, addressed to the party concerned at the address indicated below or to such other address as such party may subsequently give notice of hereunder in writing: 
 To Executive at: 
 Mory Ejabat 
 2590 Green Street. 
 San Francisco, CA 94123 
 To the Company at: 
 Zhone Technologies, Inc. 
 7001 Oakland, CA 94621 
 Fax: (510) 777-7359 
 Any notice delivered personally or by courier under this Section 20 shall be deemed given on the date delivered and any notice sent by telecopy or registered or
certified mail, postage prepaid, return receipt requested, shall be deemed given on the date telecopied or mailed. 
 21.
Severability. In the event that any one or more of the provisions of this Agreement shall be held to be invalid, illegal or unenforceable, the validity, legality and enforceability of the remainder of the Agreement shall not in any way be
affected or impaired thereby. Moreover, if any one or more of the provisions contained in this Agreement shall be held to be excessively broad as to duration, activity or subject, such provisions shall be construed by limiting and reducing them so
as to be enforceable to the maximum extent allowed by applicable law. 
 22. Survivorship. The respective rights and obligations of
the parties hereunder, including but not limited to Executive’s obligations under Sections 12 and 13, shall survive any termination of this Agreement to the extent necessary to the intended preservation of such rights and obligations.

 23. Each Party the Drafter. This Agreement and the provisions contained in it shall not be construed or interpreted for or against
any party to this Agreement because that party drafted or caused that party’s legal representative to draft any of its provisions. 
 24. Governing Law. This contract shall be governed by the laws of the State of California as they are applied to contracts between California residents to be performed completely within California. 
 25. Binding Arbitration. Except as provided in Section 14(a) of this Agreement, the parties agree that any disputes arising out of or related
to this Agreement shall be settled by binding arbitration, and judgment upon the award may be entered in any court having jurisdiction. The arbitration shall be in Palo Alto, California and in accordance with the rules of the Judicial Arbitration
and Mediation Services/Endispute in San Francisco, California. A single arbitrator shall be 

 
selected according to the corresponding arbitration rules within thirty (30) days of submission of the dispute to the arbitrator. The arbitrator shall
conduct the arbitration in accordance with the California Evidence Code. Except as expressly provided above, no discovery of any kind shall be taken by either party without the written consent of the other party, provided, however, that any party
may seek the arbitrator’s permission to take any deposition which is necessary to preserve the testimony of a witness who either is, or may become, outside the subpoena power of the arbitrator or otherwise unavailable to testify at the
arbitration. The arbitrator shall have the power to enter any award that could be entered by a Judge of the Superior Court of the State of California sitting without a jury, and only such power, except that the arbitrator shall not have the power to
award punitive damages, treble damages, or any other damages which are not compensatory, even if permitted under the laws of the State of California or any other applicable law. The arbitration award may be enforced in any court having jurisdiction
over the parties and the subject matter of the arbitration. Subject to Section 26 below, each party shall pay the fees of its own attorneys, the expenses of its witnesses and all other expenses connected with presenting its case. Other costs of
the arbitration, including the cost of any record or transcripts of the arbitration, administrative fees, the fee of the arbitrator, and all other fees and costs, shall be borne by the Company. 
 Notwithstanding the forgoing, the parties irrevocably submit to the non-exclusive jurisdiction of the Superior Court of the State of California, Santa
Clara County, and the United States District Court for the Northern District of California, Branch nearest to Palo Alto, California, in any action to enforce an arbitration award. Each party further agrees that personal jurisdiction over it may be
effected by service of process by registered or certified mail addressed as provided in Section 20 of this Agreement, and that when so made shall be as if served upon it personally within the State of California. Both Executive and the Company
expressly waive their right to a jury trial. 
 26. Attorney Fees. In the event that any dispute between the Company and Executive
should result in arbitration, the arbitrator may award to one or more of the Prevailing Persons such reasonable attorney fees, costs and expenses, as determined by the arbitrator. Any judgment or order enforcing such arbitration may, in the
discretion of the court entering such judgment or order contain, a specific provision providing for the recovery of attorney fees and costs incurred in enforcing such judgment or order and an award of prejudgment interest from the date of the breach
at the maximum rate of interest allowed by law. For the purposes of this Section 26: 
 (a) “attorney fees” shall include,
without limitation, attorney fees incurred in the following: 
 (i) arbitration; 
 (ii) post-arbitration order or judgment motions; 
 (iii) contempt proceedings; 
 (iv) garnishment, levy, and debtor and third party examinations; 
 (v) discovery; and 
 (vi) bankruptcy
litigation; 
 (b) “Prevailing Person” shall mean any person who is determined by the arbitrator in the proceeding to have
prevailed or who prevails by dismissal, default or otherwise. 
 27. Headings. All descriptive headings of sections and paragraphs in
this Agreement are intended solely for convenience, and no provision of this Agreement is to be construed by reference to the heading of any section or paragraph. 
 28. Counterparts. This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. 
 (Signature Page Follows) 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first written above.

  

							
	ZHONE TECHNOLOGIES, INC.	 		 	EXECUTIVE
				
	By:	 	 /s/ Kirk Misaka
	 		 	 /s/ Mory Ejabat

	Name:	 	Kirk Misaka	 		 	Mory Ejabat
	Title:	 	Chief Financial Officer

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00138-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00138-of-00352.parquet"}]]